drugset / Trial / NCT00239642

Safety and Efficacy of Iron Sucrose in Children

NCT00239642

Phase 4 Completed 141 enrolled American Regent, Inc.
RandomizedParallel-groupOpen-labelTreatment

Summary

Comparison of three potential iron sucrose maintenance regimens in pediatric chronic kidney disease (CKD) patients

Timeline

Start
2005-07
Primary completion
2009-01
Completion
2010-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Iron sucrose Unknown 0.5 mg/kg Intravenous
Subject Iron sucrose Unknown 1 mg/kg Intravenous
Subject Iron sucrose Unknown 2 mg/kg Intravenous